Index by author

Theranostics

• Clinical

  • You have access

    Cholecystokinin 2 Receptor Agonist ¹⁷⁷Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study

    Christof Rottenburger, Guillaume P. Nicolas, Lisa McDougall, Felix Kaul, Michal Cachovan, A. Hans Vija, Roger Schibli, Susanne Geistlich, Anne Schumann, Tilman Rau, Katharina Glatz, Martin Behe, Emanuel R. Christ and Damian Wild

    Journal of Nuclear Medicine April 1, 2020, 61 (4) 520-526; DOI: https://doi.org/10.2967/jnumed.119.233031

  • FEATURED ARTICLE OF THE MONTH

    • You have access

      Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 with ¹⁸F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard

      Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Ofer Shamni, Gilad Gitstein, Dov Hershkovitz, Nicola J. Mabjeesh, Ofer Yossepowitch, Eyal Mishani and Einat Even-Sapir

      Journal of Nuclear Medicine April 1, 2020, 61 (4) 527-532; DOI: https://doi.org/10.2967/jnumed.119.234187
  • You have access

    Comparison of 3 Interpretation Criteria for ⁶⁸Ga-PSMA11 PET Based on Inter- and Intrareader Agreement

    Akira Toriihara, Tomomi Nobashi, Lucia Baratto, Heying Duan, Farshad Moradi, Sonya Park, Negin Hatami, Carina Mari Aparici, Guido Davidzon and Andrei Iagaru

    Journal of Nuclear Medicine April 1, 2020, 61 (4) 533-539; DOI: https://doi.org/10.2967/jnumed.119.232504
  • You have access

    Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer

    Florentien J. Hinsenveld, Esther M.K. Wit, Pim J. van Leeuwen, Oscar R. Brouwer, Maarten L. Donswijk, Corinne N. Tillier, Erik Vegt, Erik van Muilekom, Matthias N. van Oosterom, Fijs W.B. van Leeuwen and Henk G. van der Poel

    Journal of Nuclear Medicine April 1, 2020, 61 (4) 540-545; DOI: https://doi.org/10.2967/jnumed.119.232199
  • You have access

    Prospective Evaluation of ¹⁸F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management

    Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon and Andrei Iagaru

    Journal of Nuclear Medicine April 1, 2020, 61 (4) 546-551; DOI: https://doi.org/10.2967/jnumed.119.231654

  • SPECIAL CONTRIBUTION

    • You have access

      Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment

      Hossein Jadvar, Leslie K. Ballas, Peter L. Choyke, Stefano Fanti, James L. Gulley, Ken Herrmann, Thomas A. Hope, Alan K. Klitzke, Jorge D. Oldan, Martin G. Pomper, Steven P. Rowe, Rathan M. Subramaniam, Samir S. Taneja, Herbert Alberto Vargas and Sukhjeet Ahuja

      Journal of Nuclear Medicine April 1, 2020, 61 (4) 552-562; DOI: https://doi.org/10.2967/jnumed.119.240929

• Basic

  • You have access

    Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: ⁶⁴Cu- and ²²⁵Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models

    Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Thomas Lindner, Kazuhiro Ooe, Atsushi Toyoshima, Kojiro Nagata, Eku Shimosegawa, Uwe Haberkorn, Clemens Kratochwil, Atsushi Shinohara, Frederik Giesel and Jun Hatazawa

    Journal of Nuclear Medicine April 1, 2020, 61 (4) 563-569; DOI: https://doi.org/10.2967/jnumed.119.233122